Unlocking Q1 Potential of Colgate-Palmolive (CL): Exploring Wall Street Estimates for Key Metrics

Core Viewpoint - Analysts project that Colgate-Palmolive (CL) will report quarterly earnings of $0.86 per share, unchanged year over year, with revenues expected to decline by 3.8% to $4.87 billion [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.2% lower over the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Pet Nutrition' to reach $1.09 billion, reflecting a decrease of 0.8% year over year [5]. - 'Net Sales- Total Oral, Personal and Home Care' is projected at $3.77 billion, indicating a decline of 4.9% from the previous year [5]. - 'Net Sales- Oral, Personal and Home Care- North America' is expected to be $1.00 billion, showing a slight increase of 0.4% year over year [5]. - 'Net Sales- Oral, Personal and Home Care- Latin America' is estimated at $1.09 billion, suggesting a significant decline of 12.6% year over year [6]. - 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' is projected to be $273.66 million, down by 0.9% year over year [6]. - 'Net Sales- Oral, Personal and Home Care- Europe' is expected to reach $674.15 million, indicating a decrease of 5.2% from the prior year [7]. - 'Net Sales- Oral, Personal and Home Care- Asia Pacific' is projected at $727.36 million, reflecting a slight increase of 0.1% year over year [7]. Operating Profit Estimates - 'Operating profit- Total Oral, Personal and Home Care' is expected to be $1.01 billion, down from $1.04 billion year over year [8]. - 'Operating profit- Pet Nutrition' is projected at $239.30 million, an increase from $199 million in the previous year [8]. - 'Operating profit- Oral, Personal and Home Care- North America' is estimated at $209.78 million, down from $222 million year over year [9]. - 'Operating profit- Oral, Personal and Home Care- Latin America' is expected to be $364.08 million, compared to $405 million last year [9]. - 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' is projected at $66.32 million, slightly up from $66 million in the same quarter last year [10]. Stock Performance - Colgate-Palmolive shares have increased by 4.2% over the past month, contrasting with the S&P 500 composite's decline of 8.9% [10].